Yizhen Chen

880 total citations
29 papers, 544 citations indexed

About

Yizhen Chen is a scholar working on Oncology, Hepatology and Molecular Biology. According to data from OpenAlex, Yizhen Chen has authored 29 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Yizhen Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver physiology and pathology (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Yizhen Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver physiology and pathology (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Yizhen Chen collaborates with scholars based in China, United States and Hong Kong. Yizhen Chen's co-authors include R. Michael Roberts, Toshihiko Ezashi, Angela M. Walker, Ronald J. Weigel, George W. Woodfield, Chi‐Chen Lin, Hezhong Dong, Yirong Li, Chieh‐Shan Wu and Yi‐Hsing Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Cell and Scientific Reports.

In The Last Decade

Yizhen Chen

25 papers receiving 534 citations

Peers

Yizhen Chen
Yumeng Huang China
Yoshiharu Suzuki Japan
Juan Zhou China
Yongqing Guo China
Takashi Kubo Japan
Yin Yin China
Richard Eccles United Kingdom
Deshan Li China
M. Okamoto Japan
Yumeng Huang China
Yizhen Chen
Citations per year, relative to Yizhen Chen Yizhen Chen (= 1×) peers Yumeng Huang

Countries citing papers authored by Yizhen Chen

Since Specialization
Citations

This map shows the geographic impact of Yizhen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhen Chen more than expected).

Fields of papers citing papers by Yizhen Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yizhen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhen Chen. The network helps show where Yizhen Chen may publish in the future.

Co-authorship network of co-authors of Yizhen Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yizhen Chen. A scholar is included among the top collaborators of Yizhen Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yizhen Chen. Yizhen Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yizhen, et al.. (2025). Low Visceral Adipose Tissue Predicts the Outcome of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Multicentre Real‐World Study. Journal of Cachexia Sarcopenia and Muscle. 16(2). e13785–e13785. 4 indexed citations
2.
Chen, Yizhen, et al.. (2025). Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study. Therapeutic Advances in Medical Oncology. 17. 22773193–22773193. 2 indexed citations
3.
Wang, Weili, Yizhen Chen, Liuting Wei, et al.. (2025). Single-cell transcriptomics combined with spatial transcriptomics reveals a fibrotic microenvironment in hyperuricemic nephropathy. European Journal of Pharmacology. 1005. 178062–178062.
4.
5.
Chen, Yizhen, Meng Cheng, Weili Wang, et al.. (2025). Identification of core noncoding RNA-associated competing endogenous RNA networks in renal fibrosis via whole-transcriptome sequencing. Renal Failure. 47(1). 2522973–2522973.
6.
Chen, Yizhen, et al.. (2025). Mechanisms and therapeutic potential of multiple forms of programmed cell death in renal fibrosis. Cellular Signalling. 134. 111926–111926. 2 indexed citations
7.
8.
Cheng, Meng, Yizhen Chen, Weili Wang, et al.. (2025). Targeting Aquaporins for Renal Fibrosis Therapy: Mechanisms and Translational Potential. The FASEB Journal. 39(16). e70967–e70967.
9.
Chen, Yizhen, et al.. (2024). Status and role of the ubiquitin–proteasome system in renal fibrosis. Biomedicine & Pharmacotherapy. 178. 117210–117210. 4 indexed citations
10.
Li, Wenjun, Jian Gao, Hong Li, et al.. (2024). Source variations of atmospheric particles in response to control measures in northern China during 2022 winter olympics and paralympics: Evidence from microscopic analysis. Environment International. 194. 109156–109156. 1 indexed citations
11.
Wang, Weili, Meng Cheng, Yizhen Chen, et al.. (2024). Metabolic reprogramming and renal fibrosis: what role might Chinese medicine play?. Chinese Medicine. 19(1). 148–148. 5 indexed citations
12.
Chen, Yizhen, Yixuan Huang, Rongfeng Huang, et al.. (2023). Interleukin-10 gene intervention ameliorates liver fibrosis by enhancing the immune function of natural killer cells in liver tissue. International Immunopharmacology. 127. 111341–111341. 10 indexed citations
13.
Huang, Yixuan, Yizhen Chen, Jiaxuan Chen, et al.. (2023). Resolvin D1 promotes the resolution of inflammation in the ACLF rat model by increasing the proportion of Treg cells. Immunity Inflammation and Disease. 11(11). e1076–e1076. 2 indexed citations
14.
Chen, Jiabing, et al.. (2022). Interleukin-10 regulates starvation-induced autophagy through the STAT3-mTOR-p70s6k axis in hepatic stellate cells. Experimental Biology and Medicine. 247(10). 832–841. 5 indexed citations
15.
16.
Chen, Jiabing, et al.. (2021). Interleukin 10 inhibits oxidative stress-induced autophagosome formation in hepatic stellate cells by activating the mTOR-STAT3 pathway. Experimental Cell Research. 411(2). 113001–113001. 9 indexed citations
17.
Chen, Yi‐Hsing, Chieh‐Shan Wu, Chi‐Chen Lin, et al.. (2016). Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice. Journal of Food and Drug Analysis. 25(3). 559–566. 92 indexed citations
18.
Xue, Likun, Tao Wang, Xinfeng Wang, et al.. (2014). On the use of an explicit chemical mechanism to dissect peroxy acetyl nitrate formation. Environmental Pollution. 195. 39–47. 61 indexed citations
19.
Bogachek, Maria V., Yizhen Chen, Mikhail V. Kulak, et al.. (2014). Sumoylation Pathway Is Required to Maintain the Basal Breast Cancer Subtype. Cancer Cell. 25(6). 748–761. 70 indexed citations
20.
Roberts, R. Michael, Yizhen Chen, Toshihiko Ezashi, & Angela M. Walker. (2007). Interferons and the maternal–conceptus dialog in mammals. Seminars in Cell and Developmental Biology. 19(2). 170–177. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yumeng Huang Breakdown of academic impact, for papers by Yoshiharu Suzuki Breakdown of academic impact, for papers by Juan Zhou Breakdown of academic impact, for papers by Yongqing Guo Breakdown of academic impact, for papers by Takashi Kubo Breakdown of academic impact, for papers by Yin Yin Breakdown of academic impact, for papers by Richard Eccles Breakdown of academic impact, for papers by Deshan Li Breakdown of academic impact, for papers by M. Okamoto
Rankless by CCL
2026